Ocular symptoms are not predictive of ophthalmologic inflammation in inflammatory bowel disease

Digestive and Liver Disease

Volumn 45, Issue 3, 2013, Pages 195-199

  Cloché, Véronique ^a   Buisson, Anthony ^a,b,c   Tréchot, Fanny ^a   Batta, Benjamine ^a   Locatelli, Andy ^a   Favel, Constance ^a   Premy, Shanour ^a   Collet Fenetrier, Benjamin ^a   Fréling, Estelle ^a   Lopez, Anthony ^a   Massoure, Marie Pauline ^a   Humbert, Anne Laure ^a   Hansmannel, Franck ^a   Guéant, Jean Louis ^a   Bigard, Marc André ^a   Peyrin Biroulet, Laurent ^a   Angioi, Karine ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b CEMAGREF   (France)

^c UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

Inflammatory bowel disease; Ocular inflammation; Ocular symptoms

Indexed keywords

ADALIMUMAB; AMINOSALICYLIC ACID; AZATHIOPRINE; BUDESONIDE; CERTOLIZUMAB PEGOL; CORTICOSTEROID; CYCLOSPORIN; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ARTICLE; BLEPHARITIS; BLURRED VISION; CROHN DISEASE; CROSS-SECTIONAL STUDY; DIPLOPIA; DISEASE DURATION; DRY EYE; ENTERITIS; EYE DISEASE; EYE EXAMINATION; EYE FUNDUS; EYE INFLAMMATION; EYE IRRITATION; EYE PAIN; EYE REDNESS; EYE WATERING; EYELID SECRETION; FEMALE; HEALTH SURVEY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; METAMORPHOSIA; MYODESOPSIA; OCULAR SYMPTOM; PREDICTIVE VALUE; PRIORITY JOURNAL; QUESTIONNAIRE; SCHIRMER TEST; SCLERITIS; SLIT LAMP; STEROID THERAPY; STRUCTURED QUESTIONNAIRE; SYMPTOM; ULCERATIVE COLITIS; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; BLEPHARITIS; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; DRY EYE SYNDROMES; EYE DISEASES; EYE PAIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; SCLERITIS; SELF REPORT; UVEITIS; VISION DISORDERS;

EID: 84875531882     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2012.10.013     Document Type: Article

References (35)

1. Peyrin-Biroulet L., Desreumaux P., Sandborn W.J., et al. Crohn's disease: beyond antagonists of tumour necrosis factor. Lancet 2008, 372:67-81.
2. Peyrin-Biroulet L., Loftus E.V., Colombel J.-F., et al. Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts. Inflammatory Bowel Diseases 2011, 17:471-478.
3. Juillerat P., Mottet C., Pittet V., et al. Extraintestinal manifestations of Crohn's disease. Digestion 2007, 76:141-148.
4. Lakatos L., Pandur T., David G., et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World Journal of Gastroenterology 2003, 9:2300-2307.
5. Felekis T., Katsanos K., Kitsanou M., et al. Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disease: a prospective single-center study. Inflammatory Bowel Diseases 2009, 15:29-34.
6. Ghanchi F.D., Rembacken B.J. Inflammatory bowel disease and the eye. Survey of Ophthalmology 2003, 48:663-676.
7. Knox D.L., Schachat A.P., Mustonen E. Primary, secondary and coincidental ocular complications of Crohn's disease. Ophthalmology 1984, 91:163-173.
8. Rankin G.B., Watts H.D., Melnyk C.S., et al. National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology 1979, 77:914-920.
9. Greenstein A.J., Janowitz H.D., Sachar D.B. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine 1976, 55:401-412.
10. Hopkins D.J., Horan E., Burton I.L., et al. Ocular disorders in a series of 332 patients with Crohn's disease. British Journal of Ophthalmology 1974, 58:732-737.
11. Salmon J.F., Wright J.P., Murray A.D. Ocular inflammation in Crohn's disease. Ophthalmology 1991, 98:480-484.
12. Matsuo T., Yamaoka A. Retinal vasculitis revealed by fluorescein angiography in patients with inflammatory bowel disease. Japanese Journal of Ophthalmology 1998, 42:398-400.
13. Angioi K., Kaminsky P., Peyrin-Biroulet L. Infliximab for severe peripheral ulcerative keratopathy revealing Crohn's disease. Inflammatory Bowel Diseases 2011, 17:866-867.
14. Diaz-Valle D., Benitez del Castillo J.M., Fernandez Aceñero M.J., et al. Bilateral lid margin ulcers as the initial manifestation of Crohn disease. American Journal of Ophthalmology 2004, 138:292-294.
15. Tappeiner C., Dohrmann J., Spital G., et al. Multifocal posterior uveitis in Crohn's disease. Graefes Archive for Clinical and Experimental Ophthalmology 2007, 245:457-459.
16. Rosenbaum J.T., Kurz D. An old crone finds a new home: Crohn's disease and pars planitis. Ocular Immunology and Inflammation 2002, 10:157-160.
17. Chowers I., Siganos C.S., Solomon A., et al. Deep stromal inflammation-a possible new ocular manifestation of Crohn's disease. Ocular Immunology and Inflammation 1998, 6:59-62.
18. Pham M., Chow C.C., Badawi D., et al. Use of infliximab in the treatment of peripheral ulcerative keratitis in Crohn disease. American Journal of Ophthalmology 2011, 152:183-188.
19. Tan M.H., Chen S.D.M., Rubinstein A., et al. Corneal perforation due to severe peripheral ulcerative keratitis in Crohn disease. Cornea 2006, 25:628-630.
20. Kelly I.M., Frith P.A., Hyman N.M., et al. Retinal periphlebitis in ulcerative colitis. Postgraduate Medical Journal 1990, 66:565-567.
21. Durno C.A., Ehrlich R., Taylor R., et al. Keeping an eye on Crohn's disease: orbital myositis as the presenting symptom. Canadian Journal of Gastroenterology 1997, 11:497-500.
22. Yilmaz S., Aydemir E., Maden A., et al. The prevalence of ocular involvement in patients with inflammatory bowel disease. International Journal of Colorectal Disease 2007, 22:1027-1030.
23. Williet N., Pillot C., Oussalah A., et al. Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics. Inflammatory Bowel Diseases 2012, 18:1641-1646.
24. Peyrin-Biroulet L., Pillot C., Oussalah A., et al. Urinary tract infections in hospitalized inflammatory bowel disease patients: a 10-year experience. Inflammatory Bowel Diseases 2012, 18:697-702.
25. Peyrin-Biroulet L., Oussalah A., Williet N., et al. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease. Gut 2011, 60:930-936.
26. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 1989, 170(Suppl.):2-6.
27. Cury D.B., Moss A.C. Ocular manifestations in a community-based cohort of patients with inflammatory bowel disease. Inflammatory Bowel Diseases 2010, 16:1393-1396.
28. Viso E., Gude F., Rodríguez-Ares M.T. The association of meibomian gland dysfunction and other common ocular diseases with dry eye: a population-based study in Spain. Cornea 2011, 30:1-6.
29. Colombel J.F., Sandborn W.J., Rutgeerts P., et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology 2007, 132:52-65.
30. Hanauer S.B., Sandborn W.J., Rutgeerts P., et al. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. Gastroenterology 2006, 130:323-333.
31. Sandborn W.J., Feagan B.G., Stoinov S., et al. Certolizumab pegol for the treatment of Crohn's disease. New England Journal of Medicine 2007, 357:228-238.
32. Schreiber S., Khaliq-Kareemi M., Lawrance I.C., et al. Maintenance therapy with certolizumab pegol for Crohn's disease. New England Journal of Medicine 2007, 357:239-250.
33. Targan S.R., Hanauer S.B., van Deventer S.J., et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease Crohn's Disease cA2 Study Group. New England Journal of Medicine 1997, 337:1029-1035.
34. Hanauer S.B., Feagan B.G., Lichtenstein G.R., et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002, 359:1541-1549.
35. Verbraak F.D., Schreinemachers M.C., Tiller A., et al. Prevalence of subclinical anterior uveitis in adult patients with inflammatory bowel disease. British Journal of Ophthalmology 2001, 85:219-221.